Tapentadol For Use In The Treatment Of Irritable Bowel Syndrome

Patent No. EP2588093 (titled "Tapentadol For Use In The Treatment Of Irritable Bowel Syndrome") was filed by Grnenthal on Jun 29, 2011. The application was issued on Jun 15, 2016.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HEXAL SANDOZMar 14, 2017LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2588093

GRNENTHAL
Application Number
EP11733571A
Filing Date
Jun 29, 2011
Status
Revoked
May 25, 2021
Publication Date
Jun 15, 2016